Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Inhibition of recombinant Hepatitis A virus proteinase 3C using Ac-Leu-Ala-Ala-OH as a substrate expressed in Escherichia coli incubated for 15 mins by SDS-PAGE assay
Assay data:2 Active, 1 Activity ≤ 1 µM, 3 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed Citation
Antiviral activity against hepatitis A virus KRM031 infected in human Huh-7.5.1 cells assessed as reduction in cytoplasmic viral RNA level at 5 to 20 uM incubated for 72 hrs dosed after infection for 6 hrs by RT-qPCR method
Assay data:1 Active, 4 Tested
SummaryCompounds, ActivePubMed Citation
Antiviral activity against hepatitis A virus HM175 infected in human Huh-7.5.1 cells assessed as reduction in HAV2c Protein expression at 10 uM incubated for 48 hrs by immunofluorescence assay
Assay data:4 Active, 4 Tested
Antiviral activity against hepatitis A virus genotype 1b infected in human Huh-7.5.1 cells assessed as reduction in virus production at 10 uM incubated for 72 hrs after 6 hrs HAV/NLuc infection by Nano-Glo luciferase assay
Antiviral activity against hepatitis A virus genotype 1b infected in human Huh-7.5.1 cells assessed as reduction in virus production incubated for 72 hrs by Nano-Glo luciferase assay
Antiviral activity against hepatitis A virus genotype 1b infected in human Huh-7.5.1 cells assessed as reduction in virus production at 10 uM incubated for 72 hrs by Nano-Glo luciferase assay
Assay data:8 Active, 42 Tested
Inhibition of HAV protease 3C expressed in Escherichia coli BL21(DE3) pLysS using Dabcyl-GLRTQSND (edans) G as substrate preincubated for 3 mins before enzyme addition by fluorescence method
Assay data:2 Active, 4 Tested
Binding affinity to Hepatitis A virus Protease 3C
Assay data:3 Active, 1 Activity ≤ 1 µM, 3 Tested
Inhibition of HRV 3C using chromogenic peptide substrate pre-incubated for 15 mins before substrate addition and measured after 1 to 2 hrs by colorimetric method
Assay data:2 Active, 3 Tested
Inhibition of HAV 3C expressed in Escherichia coli BL21(DE3) pLysS using Dabcyl-GLRTQSND (edans) G as substrate preincubated for 3 mins before enzyme addition by fluorescence method based Cheng and Prusoff equation analysis
Assay data:3 Active, 2 Activity ≤ 1 µM, 3 Tested
Inhibition of HAV 3C expressed in Escherichia coli BL21(DE3) pLysS using Dabcyl-GLRTQSND (edans) G as substrate preincubated for 3 mins before enzyme addition by fluorescence method
Activity of hepatitis A virus 3C proteinase assessed as compound hydrolysis by HPLC
Assay data:3 Active, 3 Activity ≤ 1 µM, 6 Tested
Inhibition of hepatitis A virus 3C proteinase by microplate assay
Assay data:6 Active, 5 Activity ≤ 1 µM, 6 Tested
Antiviral activity against HAV 7 in FRhK4 cells assessed as effect on cytopathogenic effect at 0.038 ug/mL after 21 days by immunofluorescence analysis
Assay data:1 Active, 1 Tested
Antiviral activity against HAV cytHB1.1 in FRhK4 cells assessed as effect on cytopathogenic effect at 0.038 ug/mL after 21 days by immunofluorescence analysis
Inhibition of HAV protease 3C
Assay data:1 Active, 1 Activity ≤ 1 µM, 1 Tested
Antiviral activity against HAV 10 ug/10'5 cells by plaque infectivity assay
Assay data:2 Active, 2 Tested
Inhibition of Hepatitis A virus His-tagged 3C-like proteinase by fluorometric assay
Assay data:4 Active, 1 Activity ≤ 1 µM, 8 Tested
Reversible inhibitory activity against Protease
Assay data:4 Active, 1 Activity ≤ 1 µM, 6 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on